EP2192987B1 - Apparatus and method for the treatment of liquids with magnetic particles - Google Patents
Apparatus and method for the treatment of liquids with magnetic particles Download PDFInfo
- Publication number
- EP2192987B1 EP2192987B1 EP08804473.0A EP08804473A EP2192987B1 EP 2192987 B1 EP2192987 B1 EP 2192987B1 EP 08804473 A EP08804473 A EP 08804473A EP 2192987 B1 EP2192987 B1 EP 2192987B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- magnetic particles
- central element
- magnetic
- liquid
- ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006249 magnetic particle Substances 0.000 title claims description 101
- 239000007788 liquid Substances 0.000 title claims description 33
- 238000000034 method Methods 0.000 title claims description 28
- 230000005291 magnetic effect Effects 0.000 claims description 29
- 239000000463 material Substances 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000003302 ferromagnetic material Substances 0.000 claims description 2
- 239000002907 paramagnetic material Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 230000005293 ferrimagnetic effect Effects 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 238000000926 separation method Methods 0.000 description 15
- 238000000265 homogenisation Methods 0.000 description 12
- 108020004707 nucleic acids Proteins 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 7
- 238000010828 elution Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000013076 target substance Substances 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000007885 magnetic separation Methods 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000009739 binding Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000002023 somite Anatomy 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- -1 RNA Chemical class 0.000 description 1
- 108020004688 Small Nuclear RNA Proteins 0.000 description 1
- 102000039471 Small Nuclear RNA Human genes 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 TeflonĀ® Polymers 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000002902 ferrimagnetic material Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/28—Magnetic plugs and dipsticks
- B03C1/288—Magnetic plugs and dipsticks disposed at the outer circumference of a recipient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/005—Pretreatment specially adapted for magnetic separation
- B03C1/01—Pretreatment specially adapted for magnetic separation by addition of magnetic adjuvants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/025—High gradient magnetic separators
- B03C1/031—Component parts; Auxiliary operations
- B03C1/033—Component parts; Auxiliary operations characterised by the magnetic circuit
- B03C1/0332—Component parts; Auxiliary operations characterised by the magnetic circuit using permanent magnets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/025—High gradient magnetic separators
- B03C1/031—Component parts; Auxiliary operations
- B03C1/033—Component parts; Auxiliary operations characterised by the magnetic circuit
- B03C1/0335—Component parts; Auxiliary operations characterised by the magnetic circuit using coils
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/02—Magnetic separation acting directly on the substance being separated
- B03C1/28—Magnetic plugs and dipsticks
- B03C1/286—Magnetic plugs and dipsticks disposed at the inner circumference of a recipient, e.g. magnetic drain bolt
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/18—Magnetic separation whereby the particles are suspended in a liquid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C2201/00—Details of magnetic or electrostatic separation
- B03C2201/26—Details of magnetic or electrostatic separation for use in medical or biological applications
Definitions
- the present invention relates to an apparatus and a method for treating liquids with magnetic particles.
- the device and the method are suitable, for example, for applications in biochemistry, clinical chemistry, molecular biology, microbiology, medical diagnostics or forensic medicine.
- the basic principle of magnetic separation of substances from complex mixtures is based on the fact that magnetic particles e.g. by chemical treatment of their surface with specific binding properties for the target substances to be separated.
- the size of such magnetic particles is generally in the range from approximately 0.05 to 500 ā m, so that they provide a large surface for the binding reaction.
- the magnetic particles can have a density that is similar to the density of the liquid in which they are suspended. In this case, sedimentation of the magnetic particles can take a few hours.
- the magnetic particles are immobilized at one point by using magnetic forces or a magnetic field, for example by means of a permanent magnet.
- This accumulation of magnetic particles is also referred to as a pellet or magnetic sediment.
- the liquid supernatant is then separated off and discarded, for example by suction or decanting. Since the magnetic particles are immobilized by the magnetic forces, magnetic particles are largely prevented from being separated off together with the supernatant.
- the immobilized magnetic particles are typically subsequently resuspended.
- An elution liquid or an elution buffer is used to enrich the bound target substances.
- the bond between the target substance and the magnetic particles are released and the target substance molecules are released from the magnetic particles.
- the target substance molecules can then be separated together with the elution liquid, while the magnetic particles are immobilized by the action of a magnetic field.
- the target substance molecules can not only be enriched, but also concentrated.
- One or more washing steps can be carried out before the elution step.
- the magnetic rod attracts the magnetic particles so that the magnetic particles adhere to the rod.
- the magnetic rod together with the magnetic particles adhering to it, is then pulled out of the reaction vessel and introduced into a second reaction vessel. There the magnetic force of the rod is then reduced or switched off, so that the magnetic particles detach from the rod and are suspended in a liquid in the reaction vessel. Similar procedures are also out of the US 6,065,605 and the WO 2005/005049 known.
- EP 0 965 842 a device is known in which the magnetic particles are drawn up together with the liquid in which they are suspended in a pipette.
- the pipette tip has a special separation area that can be acted upon by a magnet with a magnetic field. This turns the magnetic particles into pellets or magnetic sediments immobilized on the inside of the pipette tip.
- the aspirated liquid is then removed from the pipette tip by the pipetting function of the device.
- the magnetic field in the separation area can then be removed again, as a result of which the magnetic particles immobilized in the pellet are released again.
- a similar method and a similar device are in the US 6,187,270 described.
- the magnetic particles remain in the same reaction vessel while the liquid in this vessel is exchanged.
- the magnetic sediments can be immobilized at a desired height on the side wall of the reaction vessel in order to adapt to a respective process step. This is done by providing magnets which are arranged on different arms of a rotatably mounted carrier at different distances from the axis of rotation. By rotating the carrier, a specific arm - and thus a specific magnet - can be brought near the side wall of the reaction vessel. At this point, the magnetic particles are then immobilized as a pellet.
- WO 2007/063174-A describes an enrichment unit for biological components in which a magnetic rod is inserted through an opening into a bag.
- WO 99/42832-A describes a method for transferring magnetic particles with the aid of a magnet inserted into a vessel from the outside.
- WO 2004/035217-A describes a method for metering magnetic particles with the aid of a magnet inserted into a vessel from the outside.
- WO 03/072531-A1 describes an apparatus and a method for obtaining magnetic particles in a slurry phase reactor, in which the magnetic particles suspended in a liquid are guided past magnetic bars.
- the present invention is based on the object of overcoming the disadvantages arising from the prior art and, in particular, of creating a device and a method for a wide range of applications in which the treatment of liquids with magnetic particles is possible in a simple manner is.
- a device for treating a liquid with magnetic particles comprising a vessel containing the liquid and a multiplicity of magnetic particles arranged in the liquid and at least one rod-shaped, dumbbell-shaped and / or ellipsoid-shaped magnetic and / or magnetizable central element , wherein the ratio of the longest diameter d2 of the at least one central element to the ratio of the average diameter dl of the magnetic particles at least d 2nd mm ā 15 ā d 1 mm , the central element being located completely inside the vessel, the device additionally comprising at least one external magnet which is designed to interact with the at least one central element, so that the central element can be moved by the external magnet.
- central element is understood in particular to mean any object which is capable of acting through the action of a magnetic field - possibly under the action of a further āexternalā magnet (as described below) - to bind at least the majority of the magnetic particles to itself in the idle state.
- the at least one central element comprises a magnet, preferably a permanent magnet; According to an alternative, preferred embodiment of the invention, the at least one central element comprises a magnetizable material, such as e.g. Iron.
- liquids is understood to mean, but not limited to, in particular aqueous solutions, suspensions and / or two-phase emulsions with water as a phase which contain biomolecules.
- treatment in the sense of the present invention means in particular that certain biomolecules can attach to the magnetic particles in a separation step; however, the present invention is expressly not limited to this.
- diameter of the magnetic particles means in particular if the magnetic particles are not spherical or essentially spherical, the longest diameter of the magnetic particles in each case.
- average diameter means in particular the arithmetic mean of the diameter of the magnetic particles, which can be measured in particular (but not limited to) on a sample basis.
- the ratio of the longest diameter d2 of the at least one central element to the ratio of the average diameter d1 of the magnetic particles is advantageously d2 (mm) 50 50 ā d1 (mm), more preferably d2 (mm) ā 100 ā d1 (mm), further preferably d2 (mm) ā 200 ā d1 (mm), and most preferably d2 (mm) ā 300 ā d1 (mm).
- the number of magnetic particles per central element is ā 10 4 , advantageously up to ā 10 8 , preferably ā 5 x 10 5 to ā 5 x 10 6 .
- the magnetic particles contain a material selected from the group consisting of paramagnetic materials, superparamagnetic materials, ferromagnetic materials, ferrimagnetic materials and mixtures thereof.
- the average saturation magnetization of the magnetic particles is advantageously ā 1 Am 2 / kg and 250 Am 2 / kg, preferably ā 10 Am 2 / kg and 240 Am 2 / kg, and most preferably ā 20 Am 2 / kg and 235 Am 2 / kg kg. This has been found to be advantageous for many applications of the present invention.
- the at least one central element is rod-shaped, dumbbell-shaped and / or ellipsoid-shaped and the ratio of the longest diameter a to the ratio of the shortest diameter b is advantageously from a / b ā 1.1 to a / b ā 10.
- the ratio of the longest diameter a to the ratio of the shortest diameter b is advantageously from a / b 1.5 1.5 to a / b 8 8, preferably a / b 2 2 to a / b 5 5.
- the magnetic particles and the at least one central element are advantageously arranged in a closed vessel.
- the added volume V m of the magnetic particles and that of the at least one central element are 0 0.25% to 50 50% of the total volume V G of the vessel. This has proven to be favorable for many applications.
- the added volume V m of the magnetic particles and that of the at least one central element are preferably 0 0.5% to 20 20%, even more preferably 1 1% to 15 15%, of the total volume V G of the vessel.
- the device according to the invention further comprises at least one external magnet which is designed to interact with the at least one central element.
- the central element is a permanent magnet
- the ratio of the magnetic strength H 3 of the at least one external magnet to the magnetic strength H 2 of the at least one central element is according to a preferred embodiment of the invention H 3 ā 1.1 ā H 2 to H 3 ā 10 ā H 2
- the ratio of the magnetic strength H 3 of the at least one external magnet to the magnetic strength H 2 of the at least one central element is advantageously H 3 1.5 1.5 ā H 2 to H 3 8 8 ā H 2 , even more preferably H 3 2 2 ā H 2 to H 3 ā 5 ā H 2 .
- the at least one external magnet is and / or comprises an electromagnet (s) which is operated under alternating voltage for the homogenization of the magnetic particles.
- the central element is then preferably a (permanent) magnet.
- the at least one external magnet is and / or comprises a permanent magnet (s).
- the central element remains in the container throughout the process.
- step a) comprises resuspending the magnetic particles in the liquid.
- the magnetic particles were at least partially, preferably almost completely, attached to the at least one central element, and step a) takes place by the action of an external force on the at least one central element, which during the entire process the container remains.
- Step b) is advantageously supported by means of a further, external permanent magnet.
- a further, external permanent magnet is brought into the vicinity of the vessel in which the magnetic particles and the at least one central element are located.
- this allows the magnetic particles to be deposited on the at least one central element much more quickly.
- This embodiment has also proven to be particularly advantageous when the at least one central element is not a permanent magnet.
- the present invention also relates to the use of a device according to the invention and / or a method according to the invention for at least partial separation of biomolecules from / in a preferably aqueous solution.
- biomolecules all biomolecules, such as, for. B understood lipids, carbohydrates, metabolites, metabolic products, all types of nucleic acids, all types of peptides and proteins, also substituted or functionalized peptides and / or proteins.
- biomolecules is further understood - but not limited to this - to mean all molecules which occur naturally or are artificially introduced in biological samples.
- the device according to the invention and / or the method according to the invention is advantageously used for at least partial separation of nucleic acids from / in a preferably aqueous solution.
- nucleic acid in the sense of the present invention is particularly - but not limited to - natural, preferably isolated, linear, branched or circular nucleic acids such as RNA, in particular mRNA, siRNA, miRNA, snRNA, tRNA, hnRNA or ribozymes, DNA and Similar, synthetic or modified nucleic acids, for example oligonucleotides, in particular primers, probes or standards used for the PCR, nucleic acids labeled with digoxigenin, biotin or fluorescent dyes or so-called PNAs ( āpeptide nucleic acids ā) are understood.
- RNA in particular mRNA, siRNA, miRNA, snRNA, tRNA, hnRNA or ribozymes, DNA and Similar, synthetic or modified nucleic acids, for example oligonucleotides, in particular primers, probes or standards used for the PCR, nucleic acids labeled with digoxigenin, biotin or fluorescent dyes or so-called PNAs
- Fig. 1 shows a very schematic view of a device according to the invention according to an embodiment. It should be noted that 1 and 2 are highly schematic and in most applications of the inventors the actual ratios (be it size ratios such as the number of magnetic particles) will be different.
- the device comprises a plurality of first magnetic particles 10 which are attached to a central element 20 in the āidle stateā.
- Magnetic particles 10 and central magnet 20 are arranged in a (preferably closed) vessel 100, which can optionally have inlets and outlets 110 or 120 (indicated schematically in dashed lines).
- the vessel 100 is preferably filled with a liquid 150 to such an extent that the magnetic particles 10 and the central element 20 are in the liquid.
- the central element 20 is a permanent magnet; however, this is not limitative. As already described, the central element 20 can also contain a magnetizable material such as iron.
- Another embodiment for moving the at least one central element is a one-dimensional oscillating movement. Due to the effect of a magnetic field that moves back and forth on a line, the at least one central element is alternately āhewnā against the opposite vessel walls, as a result of which the magnetic particles are also effectively shaken off the central element 20.
- a shaking movement of the at least one central element can also take place by means of an electromagnet when it is operated under alternating voltage and the magnetic field polarity changes alternately, insofar this also represents a preferred embodiment of the invention. If the operating mode is changed to direct current, a magnetic separation takes place.
- the magnetic particles 10 attach themselves to the central element 20 again, so that (essentially) the state of the Fig. 1 is reached again.
- the liquid 150 can now be removed from the vessel, for example, or additional reagents can be added, depending on the specific application.
- the present example is also to be understood in a purely illustrative manner with regard to the size / volume / quantity information described or the geometric design of the reaction vessel.
- the present invention can be applied within a wide range and a person skilled in the art will accordingly choose other dimensions or arrangements.
- the option to design this as an open system see example I.
- the present invention also applies to Microsystems, such as micromixers etc., can be used very well in many applications, which is a preferred embodiment of the present invention.
- Genomic DNA was isolated from 5 ml of whole blood using the following protocol: 5 ml of blood was placed in a 30 ml beaker with a central element (standard Teflon-coated stirring fish; length 2 cm; diameter 7 mm).
- Buffer AL brand product from QIAGEN
- QIAGEN Proteinase K
- An external magnetic stirrer was used for 5 min. stirred to bind the genomic DNA to the magnetic particles.
- the supernatant was removed again and 15 ml of washing buffer AW2 (QIAGEN) were added.
- the magnetic particles were then homogenized by stirring for 60 seconds. After the stirring had stopped, the magnetic particles were deposited on the central element.
- the supernatant was removed, then the magnetic particles were air dried for 20 min.
- Buffer TE DNA Elution, QIAGEN
- the UV curve of the supernatant is in Fig. 3 to see.
- the yield can be estimated on the basis of the UV spectrum, which took place approximately quantitatively in Example 1 (approx. 170 ā g genomic DNA from 5 ml whole blood).
Landscapes
- Physical Or Chemical Processes And Apparatus (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Description
Die vorliegende Erfindung betrifft eine Vorrichtung sowie ein Verfahren zum Behandeln von FlĆ¼ssigkeiten mit magnetischen Partikeln. Die Vorrichtung sowie das Verfahren sind beispielsweise fĆ¼r Anwendungszwecke in der Biochemie, klinischen Chemie, Molekularbiologie, Mikrobiologie, medizinischen Diagnostik oder forensischen Medizin geeignet.The present invention relates to an apparatus and a method for treating liquids with magnetic particles. The device and the method are suitable, for example, for applications in biochemistry, clinical chemistry, molecular biology, microbiology, medical diagnostics or forensic medicine.
Im Stand der Technik ist eine Vielzahl von Verfahren zum Behandeln von FlĆ¼ssigkeiten mit magnetischen Partikeln bekannt, wobei sich diese meist auf das Abtrennen von NukleinsƤuren oder anderen biologisch oder biochemisch relevanten Stoffen aus einer Lƶsung beziehen.A large number of methods for treating liquids with magnetic particles are known in the prior art, these mostly relating to the separation of nucleic acids or other biologically or biochemically relevant substances from a solution.
Verfahren, die auf der magnetischen Abtrennung unter Verwendung von spezifisch und/oder unspezifisch bindenden, magnetischen Partikeln beruhen, haben im Bereich der Probenvorbereitung fĆ¼r diagnostische oder analytische Untersuchungen, insbesondere fĆ¼r die Isolierung von NukleinsƤuren, Proteinen und Zellen, zunehmende Bedeutung erlangt.Methods based on magnetic separation using specific and / or non-specific binding magnetic particles have become increasingly important in the field of sample preparation for diagnostic or analytical investigations, especially for the isolation of nucleic acids, proteins and cells.
Dies gilt insbesondere fĆ¼r automatisierte Verfahren, da auf diese Weise eine groĆe Anzahl von Proben innerhalb kurzer Zeit vorbereitet werden kƶnnen und auf arbeitsaufwendige Zentrifugationsschritte verzichtet werden kann. Dadurch werden die Voraussetzungen fĆ¼r einen effizienten und hohen Probendurchsatz geschaffen. Dies ist von enormer Bedeutung, da eine rein manuelle Handhabung von sehr groĆen Probenzahlen praktisch nicht zu bewƤltigen ist.This applies in particular to automated processes, since in this way a large number of samples can be prepared within a short time and for labor-intensive ones Centrifugation steps can be dispensed with. This creates the conditions for efficient and high sample throughput. This is of enormous importance, since the purely manual handling of very large numbers of samples is practically impossible.
Das Grundprinzip der magnetischen Abtrennung von Substanzen aus komplexen Gemischen beruht darauf, dass magnetische Partikel z.B. durch chemische Behandlung ihrer OberflƤche mit spezifischen Bindungseigenschaften fĆ¼r die abzutrennenden Zielsubstanzen ausgestattet werden. Die GrƶĆe solcher Magnetpartikel liegt im Allgemeinen im Bereich von ca. 0,05 bis 500 Āµm, so dass sie eine groĆe OberflƤche fĆ¼r die Bindungsreaktion bereitstellen. In AbhƤngigkeit von ihrer GrƶĆe und Beschaffenheit kƶnnen die magnetischen Partikel eine Dichte aufweisen, die Ƥhnlich der Dichte der FlĆ¼ssigkeit ist, in der sie suspendiert sind. In diesem Fall kann eine Sedimentierung der magnetischen Partikel durchaus einige Stunden dauern.The basic principle of magnetic separation of substances from complex mixtures is based on the fact that magnetic particles e.g. by chemical treatment of their surface with specific binding properties for the target substances to be separated. The size of such magnetic particles is generally in the range from approximately 0.05 to 500 Ī¼m, so that they provide a large surface for the binding reaction. Depending on their size and nature, the magnetic particles can have a density that is similar to the density of the liquid in which they are suspended. In this case, sedimentation of the magnetic particles can take a few hours.
Bei bekannten Trennverfahren werden die Magnetpartikel durch Anwendung magnetischer KrƤfte bzw. eines Magnetfeldes, beispielsweise mittels eines Permanentmagneten, an einer Stelle immobilisiert. Diese Ansammlung der Magnetpartikel wird auch als Pellet oder Magnetsediment bezeichnet. Nachfolgend wird der flĆ¼ssige Ćberstand beispielsweise durch Absaugen oder Dekantieren abgetrennt und verworfen. Da die Magnetpartikel durch die magnetischen KrƤfte immobilisiert sind, wird weitgehend verhindert, dass magnetische Partikel zusammen mit dem Ćberstand abgetrennt werden.In known separation processes, the magnetic particles are immobilized at one point by using magnetic forces or a magnetic field, for example by means of a permanent magnet. This accumulation of magnetic particles is also referred to as a pellet or magnetic sediment. The liquid supernatant is then separated off and discarded, for example by suction or decanting. Since the magnetic particles are immobilized by the magnetic forces, magnetic particles are largely prevented from being separated off together with the supernatant.
Typischerweise werden die immobilisierten Magnetpartikel anschlieĆend resuspendiert. Zur Anreicherung der gebundenen Zielsubstanzen wird eine ElutionsflĆ¼ssigkeit bzw. ein Elutionspuffer verwendet. Die Bindung zwischen der Zielsubstanz und den Magnetpartikeln wird gelƶst und die Zielsubstanz-MolekĆ¼le von den Magnetpartikeln freigesetzt. Die Zielsubstanz-MolekĆ¼le kƶnnen dann zusammen mit der ElutionsflĆ¼ssigkeit abgetrennt werden, wƤhrend die Magnetpartikel durch Einwirkung eines Magnetfeldes immobilisiert werden. Durch Verringerung des Volumens an ElutionsflĆ¼ssigkeit in Bezug zum primƤren Ausgangsvolumen zur Bindung, kƶnnen die Zielsubstanz-MolekĆ¼le nicht nur angereichert, sondern auch konzentriert werden. Vor dem Elutionsschritt kƶnnen ein oder mehrere Waschschritte durchgefĆ¼hrt werden.The immobilized magnetic particles are typically subsequently resuspended. An elution liquid or an elution buffer is used to enrich the bound target substances. The bond between the target substance and the magnetic particles are released and the target substance molecules are released from the magnetic particles. The target substance molecules can then be separated together with the elution liquid, while the magnetic particles are immobilized by the action of a magnetic field. By reducing the volume of elution liquid in relation to the primary starting volume for binding, the target substance molecules can not only be enriched, but also concentrated. One or more washing steps can be carried out before the elution step.
FĆ¼r die DurchfĆ¼hrung solcher Trennverfahren mittels magnetischer Partikel sind verschiedenartige Vorrichtungen beschrieben worden. So beschreibt
Dort zieht der magnetische Stab die magnetischen Partikel an, so dass die Magnetpartikel an dem Stab anhaften. Der magnetische Stab wird dann zusammen mit den daran anhaftenden magnetischen Partikeln aus dem ReaktionsgefĆ¤Ć gezogen und in ein zweites ReaktionsgefĆ¤Ć eingefĆ¼hrt. Dort wird dann die Magnetkraft des Stabes verringert bzw. abgeschaltet, so dass sich die magnetischen Partikel von dem Stab lƶsen und in einer im ReaktionsgefĆ¤Ć befindlichen FlĆ¼ssigkeit suspendiert werden. Ćhnliche Verfahren sind auch aus der
Hingegen ist aus der
Danach kann das Magnetfeld im Separationsbereich wieder entfernt werden, wodurch die im Pellet immobilisierten Magnetpartikel wieder freigegeben werden. Ein Ƥhnliches Verfahren und eine Ƥhnliche Vorrichtung sind in der
Ein anderes Prinzip zur Abtrennung magnetischer Partikel beschreibt die
Die genannten herkƶmmlichen Vorrichtungen und Verfahren weisen alle die gemeinsame Eigenschaft auf, dass sie als so genannte "offene Systeme" ausgebildet sind, da gemĆ¤Ć ihrem jeweiligen Funktionsprinzip magnetische StƤbe oder Pipetten ein- oder mehrmals in das ReaktionsgefĆ¤Ć eingefĆ¼hrt werden mĆ¼ssen. Dadurch besteht bei diesen herkƶmmlichen Vorrichtungen und Verfahren das Risiko einer Kreuzkontamination anderer ReaktionsgefƤĆe durch Aerosol- und/oder Tropfenbildung. Untersuchungsergebnisse kƶnnen verfƤlscht oder sogar unbrauchbar werden.The conventional devices and methods mentioned all have the common property that they are designed as so-called āopen systemsā, since magnetic rods or pipettes have to be introduced into the reaction vessel one or more times according to their respective functional principle. As a result, with these conventional devices and methods there is a risk of cross-contamination of other reaction vessels by aerosol and / or Drop formation. Test results can be falsified or even unusable.
Der vorliegenden Erfindung liegt die Aufgabe zugrunde, die beschriebenen, sich aus dem Stand der Technik ergebenden Nachteile zu Ć¼berwinden und insbesondere fĆ¼r eine weite Spanne von Anwendungen eine Vorrichtung sowie ein Verfahren zu schaffen, bei dem ein Behandeln von FlĆ¼ssigkeiten mit magnetischen Partikeln auf einfache Weise mƶglich ist.The present invention is based on the object of overcoming the disadvantages arising from the prior art and, in particular, of creating a device and a method for a wide range of applications in which the treatment of liquids with magnetic particles is possible in a simple manner is.
Die Aufgabe wird durch eine Vorrichtung gemĆ¤Ć Anspruch 1 der vorliegenden Erfindung gelƶst. DemgemĆ¤Ć wird eine Vorrichtung zum Behandeln von einer FlĆ¼ssigkeit mit magnetischen Partikeln beansprucht, umfassend ein GefƤĆ, enthaltend die FlĆ¼ssigkeit und eine Vielzahl von in der FlĆ¼ssigkeit angeordneten magnetischen Partikeln sowie mindestens ein stab-, hantel- und/oder ellipsoidfƶrmig ausgebildetes magnetisches und/oder magnetisierbares Zentralelement, wobei das VerhƤltnis des lƤngsten Durchmessers d2 des mindestens einen Zentralelements zum VerhƤltnis des durchschnittlichen Durchmessers dl der magnetischen Partikel mindestens
Unter dem Begriff "Zentralelement" wird im Sinne der vorliegenden Erfindung insbesondere jeder Gegenstand verstanden, welcher in der Lage ist, durch Magnetfeldeinwirkung - ggf. unter Einwirkung eines weiteren, "externen" Magneten (wie im Folgenden beschrieben) - im Ruhezustand zumindest die Mehrzahl der magnetischen Partikel an sich zu binden.For the purposes of the present invention, the term ācentral elementā is understood in particular to mean any object which is capable of acting through the action of a magnetic field - possibly under the action of a further āexternalā magnet (as described below) - to bind at least the majority of the magnetic particles to itself in the idle state.
GemĆ¤Ć einer bevorzugten AusfĆ¼hrungsform der Erfindung umfasst das mindestens eine Zentralelement einen Magneten, bevorzugt einen Permanentmagnet; gemĆ¤Ć einer alternativen, bevorzugten AusfĆ¼hrungsform der Erfindung umfasst das mindestens eine Zentralelement ein magnetisierbares Material, wie z.B. Eisen.According to a preferred embodiment of the invention, the at least one central element comprises a magnet, preferably a permanent magnet; According to an alternative, preferred embodiment of the invention, the at least one central element comprises a magnetizable material, such as e.g. Iron.
Unter dem Begriff "FlĆ¼ssigkeiten" werden - aber nicht darauf beschrƤnkt - im Sinne der vorliegenden Erfindung insbesondere wƤssrige Lƶsungen, Suspensionen und/oder zweiphasige Emulsionen mit Wasser als einer Phase, die BiomolekĆ¼le enthalten verstanden.For the purposes of the present invention, the term āliquidsā is understood to mean, but not limited to, in particular aqueous solutions, suspensions and / or two-phase emulsions with water as a phase which contain biomolecules.
Unter dem Begriff "Behandeln" im Sinne der vorliegenden Erfindung wird insbesondere verstanden, dass in einem Separationsschritt bestimmte BiomolekĆ¼le sich an die Magnetpartikel anlagern kƶnnen; die vorliegende Erfindung ist jedoch ausdrĆ¼cklich nicht darauf beschrƤnkt.The term "treatment" in the sense of the present invention means in particular that certain biomolecules can attach to the magnetic particles in a separation step; however, the present invention is expressly not limited to this.
Unter dem Begriff "Durchmesser" der Magnetpartikel ist insbesondere, wenn die Magnetpartikel nicht kugelfƶrmig oder im wesentlichen kugelfƶrmig sind, der jeweils lƤngste Durchmesser der Magnetpartikel gemeint.The term "diameter" of the magnetic particles means in particular if the magnetic particles are not spherical or essentially spherical, the longest diameter of the magnetic particles in each case.
Unter dem Begriff "durchschnittlicher Durchmesser" ist insbesondere das arithmetische Mittel der Durchmesser der Magnetpartikel gemeint, welches insbesondere (aber nicht darauf beschrƤnkt) stichprobenartig gemessen werden kann.The term "average diameter" means in particular the arithmetic mean of the diameter of the magnetic particles, which can be measured in particular (but not limited to) on a sample basis.
Eine derartige Vorrichtung bietet fĆ¼r eine weite Spanne von Anwendungen innerhalb der vorliegenden Erfindungen mindestens einen der folgenden Vorteile:
- Dadurch, dass mindestens ein Zentralelement vorgesehen ist, ist eine Homogenisierung der Magnetpartikel wie auch eine Separierung der Magnetpartikel von der Lƶsung auf einfache Weise mƶglich, wie u.a. nachfolgend beschrieben.
- Die Vorrichtung erlaubt den Einsatz in "geschlossenen" Systemen;
- Es sind keine weiteren Mittel (wie ein Stabmagnet etc.) notwendig, die direkt in die FlĆ¼ssigkeit eintauchen und somit eine potentielle Kontaminationsquelle darstellen.
- Es ergibt sich fĆ¼r die meisten Anwendungen eine sehr schnelle und leichte Homogenisierung der Magnetpartikel.
- Weiterhin ist meist eine sehr schnelle Separation der Magnetpartikel mƶglich.
- Neben dem einfachen Aufbau der Vorrichtung ist gleichzeitig der zu betreibende technische Aufwand meist sehr gering.
- Because at least one central element is provided, homogenization of the magnetic particles as well as separation of the magnetic particles from the solution is possible in a simple manner, as described below, among others.
- The device allows use in "closed"systems;
- No other means (such as a bar magnet, etc.) are necessary that are immersed directly in the liquid and thus represent a potential source of contamination.
- For most applications, the magnetic particles are homogenized very quickly and easily.
- Furthermore, very fast separation of the magnetic particles is usually possible.
- In addition to the simple construction of the device, the technical effort to be operated is usually very low.
Vorteilhafterweise ist das VerhƤltnis des lƤngsten Durchmessers d2 des mindestens einen Zentralelements zum VerhƤltnis des durchschnittlichen Durchmessers d1 der magnetischen Partikel d2 (mm) ā„ 50 ād1 (mm), noch bevorzugt d2 (mm) ā„ 100 ād1 (mm), ferner bevorzugt d2 (mm) ā„ 200 ād1 (mm), sowie am meisten bevorzugt d2 (mm) ā„ 300 ād1 (mm).The ratio of the longest diameter d2 of the at least one central element to the ratio of the average diameter d1 of the magnetic particles is advantageously d2 (mm) 50 50 ā d1 (mm), more preferably d2 (mm) ā„ 100 ā d1 (mm), further preferably d2 (mm) ā„ 200 ā d1 (mm), and most preferably d2 (mm) ā„ 300 ā d1 (mm).
Dies hat sich fĆ¼r eine breite Spanne von Anwendungen innerhalb der vorliegenden Erfindung als vorteilhaft herausgestellt, da so die gewĆ¼nschten erfinderischen Effekte oftmals auf einfache Weise erzielt werden kƶnnen.This has proven to be advantageous for a wide range of applications within the present invention, since the desired inventive effects can often be achieved in a simple manner.
GemĆ¤Ć einer bevorzugten AusfĆ¼hrungsform der Erfindung ist das VerhƤltnis des Volumens V2 des mindestens einen Zentralelements zum VerhƤltnis des durchschnittlichen Volumens V1 der magnetischen Partikel
Dies hat sich ebenfalls als gĆ¼nstig herausgestellt, da so insbesondere sichergestellt werden kann, dass nach einer Homogenisierung (Resuspendierung) der Magnetpartikel diese sich wieder an den Magneten anlagern.This has also turned out to be favorable, since it can in particular be ensured that after homogenization (resuspension) of the magnetic particles, they again attach to the magnets.
Vorteilhafterweise ist das VerhƤltnis des Volumens V2 des mindestens einen Zentralelements zum VerhƤltnis des durchschnittlichen Volumens V1 der magnetischen Partikel V2 (mm3) ā„ 100 āV1 (mm3), noch bevorzugt V2 (mm3) ā„ 1000 āV1 (mm3) sowie am meisten bevorzugt V2 (mm3) ā„ 105 āV1 (mm3).Advantageously, the ratio of the volume V2 of the at least one central element to the ratio of the average volume V1 of the magnetic particles V2 (mm 3 ) ā„ 100 ā V1 (mm 3 ), more preferably V2 (mm 3 ) ā„ 1000 ā V1 (mm 3 ) and most preferably V2 (mm 3 ) ā„ 10 5 ā V1 (mm 3 ).
GemĆ¤Ć einer bevorzugten AusfĆ¼hrungsform der Erfindung betrƤgt die Anzahl der magnetischen Partikel pro Zentralelement ā„104, vorteilhafterweise bis ā¤108, bevorzugt ā„5 x 105 bis ā¤ 5 x 106.According to a preferred embodiment of the invention, the number of magnetic particles per central element is ā„10 4 , advantageously up to ā¤10 8 , preferably ā„5 x 10 5 to ā¤ 5 x 10 6 .
GemĆ¤Ć einer bevorzugten AusfĆ¼hrungsform der Erfindung beinhalten die magnetischen Partikel ein Material, ausgewƤhlt aus der Gruppe paramagnetische Materialien, superparamagnetische Materialien, ferromagnetische Materialien, ferrimagnetische Materialien sowie Mischungen daraus.According to a preferred embodiment of the invention, the magnetic particles contain a material selected from the group consisting of paramagnetic materials, superparamagnetic materials, ferromagnetic materials, ferrimagnetic materials and mixtures thereof.
Vorteilhafterweise betrƤgt die durchschnittliche SƤttigungsmagnetisierung der magnetischen Partikel ā„1 Am2/kg und 250 Am2/kg, bevorzugt ā„10 Am2/kg und 240 Am2/kg, sowie am meisten bevorzugt ā„20 Am2/kg und 235 Am2/kg. Dies hat sich fĆ¼r viele Anwendungen der vorliegenden Erfindung als vorteilhaft herausgestellt.The average saturation magnetization of the magnetic particles is advantageously ā„1 Am 2 / kg and 250 Am 2 / kg, preferably ā„10 Am 2 / kg and 240 Am 2 / kg, and most preferably ā„20 Am 2 / kg and 235 Am 2 / kg kg. This has been found to be advantageous for many applications of the present invention.
Das mindestens eine Zentralelement ist stab-, hantel- und/oder ellipsoidfƶrmig ausgebildet und das VerhƤltnis des lƤngsten Durchmessers a zum VerhƤltnis des kĆ¼rzesten Durchmessers b ist vorteilhafterweise von a/b ā„ 1.1 bis a/b ā¤10.The at least one central element is rod-shaped, dumbbell-shaped and / or ellipsoid-shaped and the ratio of the longest diameter a to the ratio of the shortest diameter b is advantageously from a / b ā„ 1.1 to a / b ā¤10.
Dies hat sich insbesondere fĆ¼r eine einfache Homogenisierung der Magnetpartikel bei vielen Anwendungen als gĆ¼nstig herausgestellt. Vorteilhafterweise ist das VerhƤltnis des lƤngsten Durchmessers a zum VerhƤltnis des kĆ¼rzesten Durchmessers b von a/b ā„ 1.5 bis a/b ā¤8, bevorzugt a/b ā„ 2 bis a/b ā¤5.This has proven to be particularly advantageous for simple homogenization of the magnetic particles in many applications. The ratio of the longest diameter a to the ratio of the shortest diameter b is advantageously from a / b 1.5 1.5 to a / b 8 8, preferably a / b 2 2 to a / b 5 5.
Vorteilhafterweise sind die magnetischen Partikel und das mindestens eine Zentralelement in einem geschlossenen GefĆ¤Ć angeordnet.The magnetic particles and the at least one central element are advantageously arranged in a closed vessel.
GemĆ¤Ć einer bevorzugten AusfĆ¼hrungsform der Erfindung betragen das addierte Volumen Vm der magnetischen Partikel sowie das des mindestens einen Zentralelements ā„0,25% bis ā¤50% des Gesamtvolumens VG des GefƤĆes. Dies hat sich fĆ¼r viele Anwendungen als gĆ¼nstig herausgestellt.According to a preferred embodiment of the invention, the added volume V m of the magnetic particles and that of the at least one central element are 0 0.25% to 50 50% of the total volume V G of the vessel. This has proven to be favorable for many applications.
Bevorzugt betragen das addierte Volumen Vm der magnetischen Partikel sowie das des mindestens einen Zentralelements ā„0,5% bis ā¤20%, noch mehr bevorzugt ā„1% bis ā¤15%, des Gesamtvolumens VG des GefƤĆes.The added volume V m of the magnetic particles and that of the at least one central element are preferably 0 0.5% to 20 20%, even more preferably 1 1% to 15 15%, of the total volume V G of the vessel.
Die erfindungsgemƤĆe Vorrichtung umfasst weiterhin mindestens einen externen Magneten, welcher zur Interaktion mit dem mindestens einen Zentralelement ausgebildet ist. FĆ¼r den Fall, dass es sich bei dem Zentralelement um einen Permanentmagneten handelt, ist gemĆ¤Ć einer bevorzugten AusfĆ¼hrungsform der Erfindung das VerhƤltnis der MagnetstƤrke H3 des mindestens einen externen Magneten zur MagnetstƤrke H2 des mindestens einen Zentralelements
H3 ā„ 1.1ā H2 bis H3 ā¤ 10ā H2 The device according to the invention further comprises at least one external magnet which is designed to interact with the at least one central element. In the event that the central element is a permanent magnet, the ratio of the magnetic strength H 3 of the at least one external magnet to the magnetic strength H 2 of the at least one central element is according to a preferred embodiment of the invention
H 3 ā„ 1.1 ā H 2 to H 3 ā¤ 10 ā H 2
Dies hat sich als gĆ¼nstig herausgestellt, da so der mindestens eine Zentralelement auf der einen Seite erfindungemĆ¤Ć hƤufig sehr gut beeinflusst werden kann, auf der anderen Seite die Homogenisierung bzw. Anlagerung der Magnetpartikel an das mindestens eine Zentralelement nicht unnƶtig beeinflusst wird.This has turned out to be favorable, since the at least one central element can often be influenced very well according to the invention on the one hand, and the homogenization or attachment of the magnetic particles to the at least one central element is not unnecessarily influenced on the other hand.
Vorteilhafterweise ist das VerhƤltnis der MagnetstƤrke H3 des mindestens einen externen Magneten zur MagnetstƤrke H2 des mindestens einen Zentralelements H3 ā„ 1.5ā H2 bis H3 ā¤ 8ā H2, noch mehr bevorzugt H3 ā„ 2ā H2 bis H3 ā¤ 5ā H2.The ratio of the magnetic strength H 3 of the at least one external magnet to the magnetic strength H 2 of the at least one central element is advantageously H 3 1.5 1.5 ā H 2 to H 3 8 8 ā H 2 , even more preferably H 3 2 2 ā H 2 to H 3 ā¤ 5 ā H 2 .
GemĆ¤Ć einer bevorzugten AusfĆ¼hrungsform der Erfindung ist und/oder umfasst der mindestens eine externe Magnet ein(en) Elektromagnet(en), der zur Homogenisierung der magnetischen Partikel unter Wechselspannung betrieben wird. In dieser AusfĆ¼hrung ist dann bevorzugt das Zentralelement ein (Permanent-) Magnet.According to a preferred embodiment of the invention, the at least one external magnet is and / or comprises an electromagnet (s) which is operated under alternating voltage for the homogenization of the magnetic particles. In this embodiment, the central element is then preferably a (permanent) magnet.
GemĆ¤Ć einer bevorzugten AusfĆ¼hrungsform der Erfindung ist und/oder umfasst der mindestens eine externe Magnet ein(en) Permanentmagnet(en).According to a preferred embodiment of the invention, the at least one external magnet is and / or comprises a permanent magnet (s).
Die vorliegende Erfindung bezieht sich nach Anspruch 9 auĆerdem auf ein Verfahren zum Behandeln von FlĆ¼ssigkeiten mit magnetischen Partikeln mit einer Vorrichtung gemĆ¤Ć einem der AnsprĆ¼che 1 bis 8, umfassend die Schritte
- a) Verteilen der magnetischen Partikel in der FlĆ¼ssigkeit sowie nachfolgend
- b) Anlagern der magnetischen Partikel an das mindestens eine Zentralelement.
- a) Distribution of the magnetic particles in the liquid and subsequently
- b) attaching the magnetic particles to the at least one central element.
Das Zentralelement verbleibt wƤhrend des gesamten Vorgangs in dem BehƤlter.The central element remains in the container throughout the process.
Ein derartiges Verfahren bietet fĆ¼r eine weite Spanne von Anwendungen innerhalb der vorliegenden Erfindungen mindestens einen der folgenden Vorteile:
- Dadurch, dass mindestens ein Zentralelement vorgesehen ist, ist eine Homogenisierung der Magnetpartikel wie auch eine Separierung der Magnetpartikel von der Lƶsung auf einfache Weise mƶglich, wie u.a. nachfolgend beschrieben.
- Das Verfahren erlaubt den Einsatz in "geschlossenen" Systemen.
- Es sind keine weiteren Mittel (wie ein Stabmagnet etc.) notwendig, die in die FlĆ¼ssigkeit eintauchen und somit eine potentielle Kontaminationsquelle darstellen.
- Es ergibt sich fĆ¼r die meisten Anwendungen eine sehr schnelle und leichte Homogenisierung der Magnetpartikel.
- Weiterhin ist meist eine sehr schnelle Separation der Magnetpartikel mƶglich.
- Neben dem einfachen Aufbau des Verfahrens ist gleichzeitig der zu betreibende technische Aufwand meist sehr gering.
- Because at least one central element is provided, homogenization of the magnetic particles and also separation of the magnetic particles from the solution are possible in a simple manner, as described below, among others.
- The method allows use in "closed" systems.
- No other means (such as a bar magnet, etc.) are necessary that are immersed in the liquid and thus represent a potential source of contamination.
- For most applications, the magnetic particles are homogenized very quickly and easily.
- Furthermore, very fast separation of the magnetic particles is usually possible.
- In addition to the simple structure of the method, the technical effort to be operated is usually very low.
GemĆ¤Ć einer bevorzugten AusfĆ¼hrungsform der Erfindung umfasst Schritt a) eine Resuspendierung der magnetischen Partikel in der FlĆ¼ssigkeit.According to a preferred embodiment of the invention, step a) comprises resuspending the magnetic particles in the liquid.
GemĆ¤Ć einer bevorzugten AusfĆ¼hrungsform der Erfindung waren vor dem Schritt a) die magnetischen Partikel zumindest teilweise, bevorzugt fast vollstƤndig, an das mindestens eine Zentralelement angelagert und Schritt a) erfolgt durch Einwirkung einer externen Kraft auf das mindestens eine Zentralelement, welches wƤhrend des gesamten Verfahrens in dem BehƤlter verbleibt.According to a preferred embodiment of the invention, prior to step a), the magnetic particles were at least partially, preferably almost completely, attached to the at least one central element, and step a) takes place by the action of an external force on the at least one central element, which during the entire process the container remains.
Vorteilhafterweise wird Schritt b) mittels eines weiteren, externen Permanentmagneten unterstĆ¼tzt. Dabei geschieht dies bevorzugt dergestalt, dass ein externer Permanentmagnet in die NƤhe des GefƤĆes gebracht wird, in der sich die Magnetpartikel und das mindestens eine Zentralelement befinden. Dadurch kann bei vielen AusfĆ¼hrungsformen der vorliegenden Erfindung das Anlagern der Magnetpartikel an das mindestens eine Zentralelement deutlich schneller gestaltet werden. Diese AusfĆ¼hrungsform hat sich auch insbesondere dann als vorteilhaft herausgestellt, wenn das mindestens eine Zentralelement kein Permanentmagnet ist.Step b) is advantageously supported by means of a further, external permanent magnet. This is preferably done in such a way that an external permanent magnet is brought into the vicinity of the vessel in which the magnetic particles and the at least one central element are located. In many embodiments of the present invention, this allows the magnetic particles to be deposited on the at least one central element much more quickly. This embodiment has also proven to be particularly advantageous when the at least one central element is not a permanent magnet.
GemĆ¤Ć Anspruch 12 bezieht sich die vorliegende Erfindung auĆerdem auf die Verwendung einer erfindungsgemƤĆen Vorrichtung und/oder eines erfindungsgemƤĆen Verfahrens zur zumindest teilweisen Abtrennung von BiomolekĆ¼len aus/in einer vorzugsweise wƤssrigen Lƶsung.According to claim 12, the present invention also relates to the use of a device according to the invention and / or a method according to the invention for at least partial separation of biomolecules from / in a preferably aqueous solution.
Unter dem Term "BiomolekĆ¼le" werden - aber nicht darauf beschrƤnkt - im Sinne der vorliegenden Erfindung sƤmtliche BiomolekĆ¼le, wie z. B Lipide, Kohlenhydrate, Metabolite, Stoffwechselprodukte, alle Arten von NukleinsƤuren, alle Arten von Peptiden und Proteinen, auch substutierte oder funktionalisierte Peptide und/oder Proteine verstanden.Under the term "biomolecules", all biomolecules, such as, for. B understood lipids, carbohydrates, metabolites, metabolic products, all types of nucleic acids, all types of peptides and proteins, also substituted or functionalized peptides and / or proteins.
Unter dem Term "BiomolekĆ¼le" werden weiterhin - aber nicht darauf beschrƤnkt - im Sinne der vorliegenden Erfindung sƤmtlich in biologischen Proben natĆ¼rlicherweise vorkommende oder kĆ¼nstlich eingebrachte MolekĆ¼le verstanden.For the purposes of the present invention, the term ābiomoleculesā is further understood - but not limited to this - to mean all molecules which occur naturally or are artificially introduced in biological samples.
Vorteilhafterweise wird die erfindungsgemƤĆe Vorrichtung und/oder das erfindungsgemƤĆe Verfahren zur zumindest teilweisen Abtrennung von NukleinsƤuren aus/in einer vorzugsweise wƤssrigen Lƶsung verwendet.The device according to the invention and / or the method according to the invention is advantageously used for at least partial separation of nucleic acids from / in a preferably aqueous solution.
Unter dem Term "NukleinsƤure" im Sinne der vorliegenden Erfindung wird insbesondere - aber nicht darauf beschrƤnkt - natĆ¼rliche, vorzugsweise isolierte, lineare, verzweigte oder zirkulƤre NukleinsƤuren wie RNA, insbesondere mRNA, siRNA, miRNA, snRNA, tRNA, hnRNA oder Ribozyme, DNA und dergleichen, synthetische oder modifizierte NukleinsƤuren, beispielsweise Oligonukleotide, insbesondere fĆ¼r die PCR verwendete Primer, Sonden oder Standards, mit Digoxigenin, Biotin oder Fluoreszensfarbstoffen markierte NukleinsƤuren oder sogenannte PNAs ("peptide nucleic acids") verstanden.The term "nucleic acid" in the sense of the present invention is particularly - but not limited to - natural, preferably isolated, linear, branched or circular nucleic acids such as RNA, in particular mRNA, siRNA, miRNA, snRNA, tRNA, hnRNA or ribozymes, DNA and Similar, synthetic or modified nucleic acids, for example oligonucleotides, in particular primers, probes or standards used for the PCR, nucleic acids labeled with digoxigenin, biotin or fluorescent dyes or so-called PNAs ( "peptide nucleic acids ") are understood.
Die vorgenannten sowie die beanspruchten und in den AusfĆ¼hrungsbeispielen beschriebenen, erfindungsgemĆ¤Ć zu verwendenden Komponenten unterliegen in ihrer GrƶĆe, Formgestaltung, Materialauswahl und technischen Konzeption keinen besonderen Ausnahmebedingungen, so dass die in dem Anwendungsgebiet bekannten Auswahlkriterien uneingeschrƤnkt Anwendung finden kƶnnen.The size, shape, material selection and technical conception of the above-mentioned components as well as those claimed and described in the exemplary embodiments, which are to be used according to the invention, are not subject to any special exceptional conditions, so that the selection criteria known in the field of application can be used without restriction.
Weitere Einzelheiten, Merkmale und Vorteile des Gegenstandes der Erfindung ergeben sich aus den UnteransprĆ¼chen sowie aus der nachfolgenden Beschreibung der zugehƶrigen Figuren und Beispiele, in denen - beispielhaft - mehrere AusfĆ¼hrungsbeispiele sowie Einsatzmƶglichkeiten der vorliegenden Erfindung dargestellt sind.
- Fig. 1
- zeigt eine sehr schematische Ansicht einer erfindungsgemƤĆen Vorrichtung gemĆ¤Ć eines AusfĆ¼hrungsbeispiels der Erfindung vor "Homogenisierung" der Magnetpartikel;
- Fig. 2
- zeigt die Vorrichtung aus
Fig. 1 nach "Homogenisierung"; sowie - Fig. 3
- eine UV-Kurve einer DNA-Elutionslƶsung nach DurchfĆ¼hrung einer PrƤparation von genomischer DNA gemĆ¤Ć Beispiel I.
- Fig. 1
- shows a very schematic view of a device according to the invention according to an embodiment of the invention before "homogenization" of the magnetic particles;
- Fig. 2
- shows the device
Fig. 1 after "homogenization"; such as - Fig. 3
- a UV curve of a DNA elution solution after performing a preparation of genomic DNA according to Example I.
Die Vorrichtung umfasst mehrere erste Magnetpartikel 10, die im "Ruhezustand" an ein Zentralelement 20 angelagert sind. Magnetpartikel 10 und zentraler Magnet 20 sind dabei in einem (vorzugsweise geschlossenen) GefĆ¤Ć 100 angeordnet, welches wahlweise Ć¼ber (schematisch strichartig angedeutete) Ein- und AblƤsse 110 bzw. 120 verfĆ¼gen kann. Das GefĆ¤Ć 100 ist vorzugsweise mit einer FlĆ¼ssigkeit 150 so hoch gefĆ¼llt, dass sich die Magnetpartikel 10 und das Zentralelement 20 in der FlĆ¼ssigkeit befinden.The device comprises a plurality of first
In der vorliegenden AusfĆ¼hrungsform ist das Zentralelement 20 ein Permanentmagnet; dies ist jedoch nicht beschrƤnkend. Wie bereits geschildert kann das Zentralelement 20 auch ein magnetisierbares Material wie Eisen enthalten.In the present embodiment, the
Durch Bewegen des Zentralelements 20 (z.B. durch Drehen in Richtung des Pfeils A oder alternativ durch RĆ¼tteln), welches vorzugsweise mittels eines weiteren (in der Fig. nicht gezeigten) Magneten erfolgt, ist es mƶglich, die Magnetpartikel von dem Zentralelement 20 zu "lƶsen" (quasi "abzuschĆ¼tteln") und im GefĆ¤Ć zu verteilen, so dass sich (abhƤngig von der konkreten Anwendung) z.B. BiomolekĆ¼le an die Magnetpartikel anlagern kƶnnen.By moving the central element 20 (for example by rotating in the direction of arrow A or alternatively by shaking), which is preferably carried out by means of a further magnet (not shown in the figure), it is possible to "detach" the magnetic particles from the central element 20 (quasi "shake off") and distribute in the vessel, so that (depending on the specific application) eg Can attach biomolecules to the magnetic particles.
Es sei an dieser Stelle darauf hingewiesen, dass es sich bei vielen Anwendungen der vorliegenden Erfindung als gĆ¼nstig erwiesen hat, dass, wenn eine Kreis- (oder kreisartige) Bewegung des Zentralelements 20 stattfindet, der Mittelpunkt dieses "imaginƤren" Kreises sich nicht in der NƤhe des Mittelpunktes des GefƤĆes 100 befindet. Durch diese Anordnung wird oftmals bewirkt, dass die Magnetpartikel 10 bei der Homogenisierung vom Zentralelement 20 regelrecht "weggeschleudert" werden, was den Schritt der Homogenisierung nochmals erleichtert. Somit stellt dies eine bevorzugte AusfĆ¼hrungsform der vorliegenden Erfindung dar.It should be noted at this point that, in many applications of the present invention, it has been found beneficial that when a circular (or circular) movement of the
Eine weitere AusfĆ¼hrungsform zur Bewegung des mindestens einen Zentralelements ist eine eindimensionale oszillierende Bewegung. Durch die Auswirkung eines Magnetfeldes, das sich auf einer Linie vor- und zurĆ¼ckbewegt, wird das mindestens eine Zentralelemente alternierend an die gegenĆ¼berliegenden GefƤĆwƤnde "gehauen", wodurch die Magnetpartikel von dem Zentralelement 20 auch effektiv abgeschĆ¼ttelt werden.Another embodiment for moving the at least one central element is a one-dimensional oscillating movement. Due to the effect of a magnetic field that moves back and forth on a line, the at least one central element is alternately āhewnā against the opposite vessel walls, as a result of which the magnetic particles are also effectively shaken off the
Eine RĆ¼ttelbewegung des mindestens einen Zentralelements kann auch mittels eines Elektromagneten erfolgen wenn dieser unter Wechselspannung betrieben wird und sich die Magnetfeld-Polung alternierend Ƥndert, insofern stellt dies ebenfalls eine bevorzugte AusfĆ¼hrungsform der Erfindung dar. Ćndert man die Betriebsart auf Gleichstrom so findet eine Magnetseparation statt.A shaking movement of the at least one central element can also take place by means of an electromagnet when it is operated under alternating voltage and the magnetic field polarity changes alternately, insofar this also represents a preferred embodiment of the invention. If the operating mode is changed to direct current, a magnetic separation takes place.
Der Zustand nach dieser "Homogenisierung" ist sehr schematisch in
Wird die Bewegung des Zentralelements 20 gestoppt, so lagern sich die Magnetpartikel 10 wieder an das Zentralelement 20 an, so dass (im Wesentlichen) der Zustand der
Die Erfindung wird nachfolgend ebenfalls anhand von Beispielen erlƤutert. Es versteht sich, dass diese rein illustrativ zu betrachten sind und keine EinschrƤnkung der vorliegenden Erfindung darstellen sollen, welche ausschlieĆlich durch die AnsprĆ¼che festgelegt wird.The invention is also explained below using examples. It goes without saying that these are to be considered purely for illustrative purposes and are not intended to represent a restriction of the present invention, which is defined exclusively by the claims.
Es sei insbesondere explizit angemerkt, dass das vorliegende Beispiel auch im Hinblick auf die beschriebenen GrƶĆen-/Volumen-/Mengenangaben bzw. die geometrischen Gestaltungsformen des ReaktionsgefƤĆes rein illustrativ zu verstehen ist. Die vorliegende Erfindung ist, wie sich bei vielen Anwendungen und AusfĆ¼hrungsbespielen gezeigt hat, innerhalb einer weiten GrƶĆenordnung anwendbar und ein Fachmann wird dementsprechend andere Dimensionen bzw. Anordnungen wƤhlen. Neben dem Vorteil das Verfahren als geschlossenes System zu betreiben, liegt natĆ¼rlich die Option offen dies auch als offenes System zu gestalten (siehe Beispiel I). Insbesondere hat sich gezeigt, dass die vorliegende Erfindung auch bei Mikrosystemen, wie Mikromischern etc., bei vielen Anwendungen sehr gut einsetzbar ist, was eine bevorzugte AusfĆ¼hrungsform der vorliegenden Erfindung darstellt.In particular, it should be explicitly noted that the present example is also to be understood in a purely illustrative manner with regard to the size / volume / quantity information described or the geometric design of the reaction vessel. As has been shown in many applications and exemplary embodiments, the present invention can be applied within a wide range and a person skilled in the art will accordingly choose other dimensions or arrangements. In addition to the advantage of operating the process as a closed system, there is of course the option to design this as an open system (see example I). In particular, it has been shown that the present invention also applies to Microsystems, such as micromixers etc., can be used very well in many applications, which is a preferred embodiment of the present invention.
Aus 5 ml Vollblut wurden mittels des folgenden Protokolls die genomische DNA isoliert:
5 ml Blut wurden in ein 30 ml Becherglas mit einem Zentralelement (Standard Teflon-ummantelter RĆ¼hrfisch; LƤnge 2 cm; Durchmesser 7 mm) gegeben.Genomic DNA was isolated from 5 ml of whole blood using the following protocol:
5 ml of blood was placed in a 30 ml beaker with a central element (standard Teflon-coated stirring fish; length 2 cm; diameter 7 mm).
AnschlieĆend wurden 5 ml Buffer AL (Markenprodukt der Fa. QIAGEN) sowie 500 Āµl Proteinase K (QIAGEN) zugegeben. Es erfolgte eine Inkubation fĆ¼r 30 min bei 60Ā°C auf einem MagnetheizrĆ¼hrer bei langsamer RĆ¼hrgeschwindigkeit.5 ml of Buffer AL (branded product from QIAGEN) and 500 Ī¼l of Proteinase K (QIAGEN) were then added. There was an incubation for 30 min at 60 Ā° C on a magnetic heating stirrer at a slow stirring speed.
Danach wurden 5 ml Isopropanol und 500 Āµl MagAttract Suspension G (QIAGEN) zugegeben, welche die Magnetpartikel enthielt; der durchschnittliche Durchmesser der Partikel ist 8 Āµm.Then 5 ml of isopropanol and 500 Ī¼l of MagAttract Suspension G (QIAGEN) were added, which contained the magnetic particles; the average diameter of the particles is 8 Āµm.
Mittels eines externen MagnetrĆ¼hrers wurde 5 min. gerĆ¼hrt, um die genomische DNA an die Magnetpartikel zu binden.An external magnetic stirrer was used for 5 min. stirred to bind the genomic DNA to the magnetic particles.
AnschlieĆend wurde der RĆ¼hrer gestoppt, worauf sich die Magnetpartikel an das Zentralelement anlagerten. Der Ćberstand wurde entfernt, anschlieĆend wurden 15 ml Waschpuffer AW1 (QIAGEN) zugeben. Es erfolgte eine Homogenisieren der Magnetpartikel durch RĆ¼hren fĆ¼r 60 sec, anschlieĆend erneut eine Magnetseparation durch RĆ¼hrstopp.The stirrer was then stopped, whereupon the magnetic particles accumulated on the central element. The supernatant was removed, then 15 ml of wash buffer AW1 (QIAGEN) were added. Homogenization was carried out the magnetic particles by stirring for 60 seconds, then again a magnetic separation by stopping the stirring.
Es erfolgte ein erneutes Entfernen des Ćberstandes sowie die Zugabe von 15 ml Waschpuffer AW2 (QIAGEN). Danach wurden die Magnetpartikel durch RĆ¼hren fĆ¼r 60 sec. Homogenisiert. Nach RĆ¼hrstopp erfolgte eine Anlagerung der Magnetpartikel an das Zentralelement.The supernatant was removed again and 15 ml of washing buffer AW2 (QIAGEN) were added. The magnetic particles were then homogenized by stirring for 60 seconds. After the stirring had stopped, the magnetic particles were deposited on the central element.
Der Ćberstand wurde entfernt, danach erfolgte ein Lufttrocknen der Magnetpartikel fĆ¼r 20 min.The supernatant was removed, then the magnetic particles were air dried for 20 min.
Um die DNA zu eluieren wurden 5 ml Buffer TE (DNA Elution, QIAGEN) zugegeben. Danach wurden die Magnetpartikel durch RĆ¼hren fĆ¼r 5 min homogenisiert, nach RĆ¼hrstopp erfolgte die Anlagerung der Magnetpartikel an das Zentralelement.5 ml of Buffer TE (DNA Elution, QIAGEN) were added to elute the DNA. The magnetic particles were then homogenized by stirring for 5 min. After the stirring had stopped, the magnetic particles were deposited on the central element.
Der Ćberstand, der nun die DNA enthielt, wurde in ein geeignetes Lagerungsrƶhrchen Ć¼berfĆ¼hrt und die DNA-Konzentration durch UV-Quantifizierung und OD Scan gemessen.The supernatant, which now contained the DNA, was transferred to a suitable storage tube and the DNA concentration was measured by UV quantification and OD scan.
Die UV-Kurve des Ćberstandes ist in
Claims (12)
- Apparatus for the treatment of a liquid with magnetic particles, comprising a vessel (100) containing the liquid (150) and a plurality of magnetic particles (10) arranged in the liquid (150) and at least one magnetic and/or magnetizable central element (20) formed in bar shape, dumbbell shape or ellipsoidal shape, wherein the ratio of the longest diameter d2 of the at least one central element (20) to the ratio of the average diameter d1 of the magnetic particles (10) is at least
- Apparatus according to claim 1, wherein the ratio of the volume V2 of the at least one central element (20) to the ratio of the average Volume V1 of one magnetic particle (10) is V2 (mm3) ā„ 10āV1 (mm3).
- Apparatus according to claim 1, wherein the number of magnetic particles (10) per central element (20) is ā„ 104.
- Apparatus according to one of claims 1 to 3, wherein the magnetic particles (10) include a material selected from the group of paramagnetic materials, superparamagnetic materials, ferromagnetic materials, ferrimagnetic particles and mixtures thereof.
- Apparatus according to one of claims 1 to 4, wherein the added volume Vm of the magnetic particles (10) and the at least one central element (20) is ā„0.25% to ā¤50% of the total volume VG of the vessel (100).
- Apparatus according to one of claims 1 to 5, wherein the central element (20) comprises at least one permanent magnet and the ratio of the magnetic strength H3 of the at least one external magnet to the magnetic strength H2 of the at least one central element (20) is H3 ā„ 1.1āH2 to H3 ā¤ 10āH2.
- Apparatus according to one of claims 1 to 6, wherein the at least one external magnet is an electromagnet.
- Apparatus according to one of claims 1 to 6, wherein the at least one external magnet is a permanent magnet.
- Method for treating liquids with magnetic particles (10) with an apparatus according to one of claims 1 to 8, comprising the stepsa) distributing the magnetic particles (10) in the liquid (150) and subsequentlyb) attaching the magnetic particles (10) to the at least one central element (20).
- Method according to claim 9, characterized in that step a) comprises resuspending the magnetic particles (10) in the liquid (150).
- Method according to claim 9 or 10, characterized in that prior to step a) the magnetic particles (10) were at least partially attached to the at least one central element (20) and that step a) occurs due to a force acting on the at least one central element (20).
- Use of an apparatus according to one of claims 1 to 8 and/or of a method according to one of claims 9 to 11 for at least partially separating biomolecules from/in a preferably aqueous solution.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007045474A DE102007045474A1 (en) | 2007-09-21 | 2007-09-21 | Apparatus and method for treating liquids with magnetic particles |
PCT/EP2008/062539 WO2009040312A1 (en) | 2007-09-21 | 2008-09-19 | Apparatus and method for the treatment of liquids with magnetic particles |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2192987A1 EP2192987A1 (en) | 2010-06-09 |
EP2192987B1 true EP2192987B1 (en) | 2020-04-22 |
Family
ID=40350080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08804473.0A Active EP2192987B1 (en) | 2007-09-21 | 2008-09-19 | Apparatus and method for the treatment of liquids with magnetic particles |
Country Status (5)
Country | Link |
---|---|
US (1) | US8361326B2 (en) |
EP (1) | EP2192987B1 (en) |
JP (1) | JP5336495B2 (en) |
DE (1) | DE102007045474A1 (en) |
WO (1) | WO2009040312A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2574931B1 (en) | 2011-09-29 | 2017-03-22 | Qiagen GmbH | Dry composition comprising a control dye |
WO2013053855A1 (en) | 2011-10-11 | 2013-04-18 | Qiagen Gmbh | Sample processing method and sample processing cartridge |
JP2015159733A (en) * | 2014-02-26 | 2015-09-07 | ć»ć¤ć³ć¼ćØćć½ć³ę Ŗå¼ä¼ē¤¾ | Lyophilizate of substance binding solid-phase carrier, vessel to bind substance in substance-containing liquid to substance binding solid-phase carrier, and manufacturing method of lyophilizate containing substance binding solid-phase carrier |
WO2016193281A1 (en) | 2015-06-01 | 2016-12-08 | Qiagen Gmbh | Electrophoresis assisted method and device for purifying a charged target molecule from a sample |
US10711265B2 (en) | 2015-06-01 | 2020-07-14 | Qiagen Gmbh | Electrophoresis assisted method for purifying a target nucleic acid using a delayed elution approach |
KR101834828B1 (en) | 2017-06-02 | 2018-03-07 | ķźµź³¼ķźø°ģ ģ | Bacteria concentration method using magnetic force |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003072531A1 (en) * | 2002-02-01 | 2003-09-04 | Exportech Company, Inc. | Process and apparatus for recovery of magnetic particles in a slurry phase reactor |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8400855A (en) | 1984-03-16 | 1985-10-16 | Wagemans Maastricht B V | SPRING HINGE. |
JPH04102062A (en) * | 1990-08-22 | 1992-04-03 | Hitachi Ltd | Method for measuring particle immunity |
US5897783A (en) * | 1992-09-24 | 1999-04-27 | Amersham International Plc | Magnetic separation method |
DE4423878A1 (en) | 1994-07-07 | 1996-01-11 | Boehringer Mannheim Gmbh | Device and method for separating magnetic microparticles |
FI944940A0 (en) | 1994-10-20 | 1994-10-20 | Labsystems Oy | Tvaofasigt separeringsfoerfarande |
FI944939A0 (en) * | 1994-10-20 | 1994-10-20 | Labsystems Oy | Foerfarande Foer separering av partiklar |
AU738336B2 (en) | 1996-05-20 | 2001-09-13 | Precision System Science Co., Ltd. | Control method and apparatus for controlling magnetic particles by a sample distributor |
EP0905520B1 (en) | 1997-09-29 | 2008-03-26 | F. Hoffmann-La Roche Ag | Apparatus for separating magnetic particles |
FI102906B (en) * | 1998-02-23 | 1999-03-15 | Bio Nobile Oy | Procedure and means for transporting a substance |
FI20000583A0 (en) | 2000-03-14 | 2000-03-14 | Labsystems Oy | Dish and rod |
FI120863B (en) * | 2002-10-18 | 2010-04-15 | Biocontrol Systems Inc | Magnetic transfer method and microparticle transfer device |
DE10331254B4 (en) * | 2003-07-10 | 2006-05-04 | Chemagen Biopolymer-Technologie Aktiengesellschaft | Apparatus and method for separating magnetic or magnetizable particles from a liquid |
FI20051248L (en) * | 2005-12-02 | 2007-06-03 | Bio Nobile Oy | Enrichment unit and enrichment method for biological components |
-
2007
- 2007-09-21 DE DE102007045474A patent/DE102007045474A1/en not_active Withdrawn
-
2008
- 2008-09-19 US US12/676,376 patent/US8361326B2/en active Active
- 2008-09-19 EP EP08804473.0A patent/EP2192987B1/en active Active
- 2008-09-19 JP JP2010525360A patent/JP5336495B2/en active Active
- 2008-09-19 WO PCT/EP2008/062539 patent/WO2009040312A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003072531A1 (en) * | 2002-02-01 | 2003-09-04 | Exportech Company, Inc. | Process and apparatus for recovery of magnetic particles in a slurry phase reactor |
Also Published As
Publication number | Publication date |
---|---|
DE102007045474A1 (en) | 2009-04-02 |
JP5336495B2 (en) | 2013-11-06 |
WO2009040312A1 (en) | 2009-04-02 |
US20100307981A1 (en) | 2010-12-09 |
EP2192987A1 (en) | 2010-06-09 |
JP2010539502A (en) | 2010-12-16 |
US8361326B2 (en) | 2013-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1446668B1 (en) | Device and method for treating magnetic particles | |
EP2033715B1 (en) | Method for suspending or re-suspending particles in a solution and device adapted therefor | |
EP1919625B1 (en) | Device and method for the separation of magnetic particles from a liquid | |
EP1843854B1 (en) | Device and method for the elimination of magnetic or magnetizable particles from a liquid | |
EP1644120B1 (en) | Device and method for removing magnetic or magnetisable particles from a liquid | |
EP2192987B1 (en) | Apparatus and method for the treatment of liquids with magnetic particles | |
EP1420888B1 (en) | System for separating magnetically attractable particles | |
DE69600924T2 (en) | APPARATUS AND METHOD FOR MIXING AND SEPARATING THROUGH MAGNETIC PARTICLES | |
DE102006002258B4 (en) | Module for the preparation of a biological sample, biochip set and use of the module | |
DE10057396C1 (en) | Separation of e.g. biomolecules from dispersion or solution, employs magnetic particles onto which substance is sorbed, and electromagnet for their extraction | |
DE60207564T2 (en) | TREATMENT METHOD FOR MAGNETIC PARTICLES AND BIOANALYSIS APPARATUS USING MAGNETIC APPLICATION | |
DE60023185T2 (en) | APPARATUS AND METHOD FOR MIXING AND DISCONNECTING USING MAGNETIC PARTICLES | |
WO2018167138A1 (en) | Process for concentrating cells from a sample and then isolating nucleic acids from said cells | |
EP3693739A1 (en) | Method and device for isolating desired cells from a sample of nonmagnetic biological material | |
DE19854003A1 (en) | Simultaneous magnetic particle handling in a two-dimensional arrangement | |
DE112019004459T5 (en) | ENRICHMENT OF SAMPLES BY MEANS OF MAGNETIC PARTICLES IN MICROCHANNELS | |
EP3147028B1 (en) | Method and system for magnetic separation of nano-beads | |
EP3710163A1 (en) | Device and method for reversibly immobilising biomolecules | |
DE19955169A1 (en) | Solenoids with air gap to influence magnetic particles in fluid in a titration plate, is useful for mixing, vibration, precipitation and filtration | |
DE102023102183A1 (en) | SUSPENSION PROCESSES FOR MAGNETIC PARTICLES | |
WO2007000399A1 (en) | Carrier material, method for the production and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100421 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20130605 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 502008017067 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: B03C0001280000 Ipc: B03C0001033000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: B03C 1/01 20060101ALI20191219BHEP Ipc: B03C 1/033 20060101AFI20191219BHEP Ipc: B03C 1/28 20060101ALI20191219BHEP |
|
INTG | Intention to grant announced |
Effective date: 20200113 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502008017067 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1259374 Country of ref document: AT Kind code of ref document: T Effective date: 20200515 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200824 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200822 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200722 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200723 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200722 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502008017067 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20210125 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20200930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200919 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200930 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200930 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200919 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200930 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 1259374 Country of ref document: AT Kind code of ref document: T Effective date: 20200919 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200919 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230920 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230928 Year of fee payment: 16 Ref country code: DE Payment date: 20230920 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230927 Year of fee payment: 16 |